|
Where we are What's new? |
 |
Conference Presentations 2003Below are listed conference presentations (oral presentations, posters, free communications, etc) presented by members of the Centre for Kidney Research in 2003. 12th National Conference on Incontinence, Manly, NSW, 3-6 Dec 2003Caldwell P. Current approach at the Children's Hospital at Westmead. Is there a way to determine best practice for a wetting clinic? [Invited speaker] 21st Annual Scientific Meeting. Transplantation Society of Australia and New Zealand. Canberra, ACT, 9-11 April 2003Webster AC, Higgins G, Chapman JR, Craig JC Tacrolimus for renal transplant recipients: a meta-analysis of randomised controlled trials 21st Annual Scientific Meeting, p.64 [Oral presentation] Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC IL2 receptor antagonists for renal transplant recipients: a meta-analysis of randomised controlled trials 21st Annual Scientific Meeting, p.58 [Poster presentation] 36th Annual Meeting. American Society of Nephrology. San Diego,CA, 12-17 Nov 2003Strippoli GFM, Craig M, Schena FP, Craig JC Improved survival with ACE inhibitors compared with angiotensin II receptor antagonists in patients with diabetic nephropathy Journal of the American Society of Nephrology 2003; 14:6A [Oral presentation] Roberts MA,Flanc RS, Strippoli GFM, Kerr PG, Chadban SJ, Atkins RC Meta-analysis of treatment options for diffuse proliferative lupus nephritis (DPLN) Journal of the American Society of Nephrology 2003; 14:450A [Poster presentation] Strippoli GFM, Craig JC, Manno C, Schena FP Nephrology and randomized trials. Are we asking intervention questions? Are we asking them right? Journal of the American Society of Nephrology 2003; 13: 4A [Poster presentation] 39th Annual Meeting. Australian and New Zealand Society of Nephrology. Perth,WA 1-3 Sept 2003.Strippoli GFM, Craig M, Schena FP, Craig JC Delaying the progression of diabetic nephropathy with antihypertensive agents: a meta-analysis of randomised trials Nephrology 2003; 8(Suppl):A90 [Poster presentation] Hodson EM, Jones CA, Barclay P, Kable K, Craig JC Interventions for preventing cytomegalovirus (CMV) disease in solid organ transplant recipients: a meta-analysis of randomised controlled trials (RCT) Nephrology 2003; 8 (Suppl):A66 [Poster presentation] Flanc RS, Roberts MA, Strippoli GFM, Kerr PG, Chadban SJ, Atkins RC Meta-analysis of treatment options for diffuse proliferative lupus nephritis (DPLN) Nephrology 2003; 8 (Suppl):A62 [Poster presentation] Strippoli GFM, Samuels JA, Schena FP, D. A. Molony, Craig JC. Treatment with immunosuppressive agents for IgA nephropathy: a meta-analysis of randomised trials Nephrology 2003; 8 (Suppl):A61 [Poster presentation] Wu H, Wang YP, Zheng GP, Alexander SI, Harris DCH DNA vaccination with naked DNA encoding Mcp-1 and rantes protects glomerular and institial injury in adriamycin nephropathy Nephrology 2003; 8 (Suppl):A80 [Poster presentation] Wu H, Wang YP, Knight JF, Harris DCH, Alexander SI A protective role of gd T cells in murine adriamycin-induced nephrology: a potential role for Nkg2d activation by rae1 Nephrology 2003; 8 (Suppl):A79 [Poster presentation] International Society of Nephrology. World Congress of Nephrology, Berlin, Germany, 8-12 June 2003Webster A, Chapman J, Craig J Prevalence and impact of overt and covert duplicate publication of randomised trials in renal transplantation Nephrology Dialysis Transplantation 2003;18 (Suppl 4):p779 [Poster presentation] Samuels JA, Strippoli GFM, Schena FP, Manno C, Molony D, Craig JC Immunosuppressive agents for IgA nephropathy: a meta-analysis of randomized controlled trials Nephrology Dialysis Transplantation 2003; 18 (Suppl 4):p.343 [Poster presentation] Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomised trials Nephrology Dialysis Transplantation 2003, 18 (Suppl 4): p.495 [Poster presentation] Webster A, Chapman J, Craig J Prevalence and impact of overt and covert duplicate publication of randomised trials in renal transplantation Nephrology 2003; 8 (Suppl ):A75 [Poster presentation] Strippoli GFM, Craig JC, Schena FP Research in nephrology: few intervention trials, many basic science publications Nephrology Dialysis Transplantation 2003; 18 (Suppl 4):p.117 [Poster presentation] Webster AC, Higgins G, Chapman JR, Craig JC Tacrolimus for renal transplant recipients: a meta-analysis of randomised controlled trials Nephrology Dialysis Transplantation 2003; 18 (suppl 4):p.789 [Poster presentation] Strippoli GFM, Webster A, Manno C, Schena FP, Craig JC Treatment for idiopathic membranous nephropathy: a meta-analysis of randomized controlled trial evidence Nephrology Dialysis Transplantation 2003; 18 (Suppl 4):p.616 [Poster presentation] International Society of Hemodialysis 2003Mezza E, Grassi G, Faggiano F, Bermond F, Calderini M, Sampo' D, Gentile L, Piccoli GB Dialysis or transplantation for end-stage renal disease in adults? An evidence-based answer Hemodialysis International 2003; 7(1):73 [Poster presentation] Royal Australasian College of Physicians [RACP]. Annual Scientific Meeting. Hobart,TAS, 26-28 May 2003.Caldwell PHY, Craig JC, Hamilton S, Butow PN. Recruitment strategies for recruitment to RCTs: a systematic review of controlled trials and observational studies [Poster presentation] Caldwell PHY, Butow PN, Craig JC. Parents' attitudes to randomised controlled trials involving children [Poster presentation] Caldwell PHY, Craig JC, Butow PN. Questionnaire on attitudes of Australian physicians and paediatricians to randomised controlled trials (RCTs) [Poster presentation] |